Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 101

Sort by

Sort Order Select

Journal Articles

A Balancing Act: Outcomes of Post-Transplant Cyclophosphamide in Older Patients

Herman Van Besien, Samuel Yamshon, Alexandra Gomez-Arteaga, Nora Chokr, Sebastian A. Mayer, Michelle S Pasciolla, Rachel Abramova, Tsiporah B. Shore, Juliet N Barker, Anna Alperovich

Blood (2024) 144 (Supplement 1): 7375.

https://doi.org/10.1182/blood-2024-211361

Published: 2024

Journal Articles

Non-White and Hispanic Patients Have Significantly Longer Time from Intent to CAR T Infusion (“Brain-to-Vein” Time) in Multiply Relapsed Diffuse Large B Cell Lymphoma

Neela Easwar, Anna Alperovich, Alexandra Gomez-Arteaga, Sebastian A. Mayer, Nora Chokr, Adrienne A. Phillips, Jingmei Hsu, Koen van Besien, Matthew Gromowsky, Matthew Lunning, Tsiporah B. Shore, Juliet N Barker, Samuel Yamshon

Blood (2024) 144 (Supplement 1): 2351.

https://doi.org/10.1182/blood-2024-201337

Published: 2024

Journal Articles

Optimized Double-Unit Cord Blood Transplantation Mitigates Transplant-Related Mortality Resulting in High Progression-Free Survival in Adults with Hematologic Malignancies

Ioannis Politikos, Sean M. Devlin, Stephanie Chinapen, Sean Quach, Parastoo B. Dahi, Boglarka Gyurkocza, Ann A. Jakubowski, Esperanza B. Papadopoulos, Doris M. Ponce, Roni Tamari, Andromachi Scaradavou, Juliet N Barker

Blood (2023) 142 (Supplement 1): 4916.

https://doi.org/10.1182/blood-2023-190528

Published: 2023

Journal Articles

Analysis of 3,843 Unrelated Donors (URD) for 455 Allograft Candidates Reveals Low URD Availability with Marked Racial/ Ethnic Disparities: Major Implications for Transplant Center & Registry Operations

Warren B Fingrut, Eric Davis, Anne Archer, Samantha Brown, Sean M. Devlin, Melissa Nhaissi, Candice Rapoport, Stephanie Chinapen, Amanda Kelly, Deborah Wells, Andromachi Scaradavou, Boglarka Gyurkocza, Esperanza B. Papadopoulos, Ioannis Politikos, Brian C. Shaffer, Juliet N Barker

Blood (2023) 142 (Supplement 1): 5114.

https://doi.org/10.1182/blood-2023-180439

Published: 2023

Journal Articles

Gender Disparities in Allograft Access Due to HLA-Sensitization in Multiparous Women: Implications for Evaluation of Female Patients for Alternative Donor Transplantation

Warren B Fingrut, Eric Davis, Anne Archer, Samantha Brown, Sean M. Devlin, Stephanie Chinapen, Andromachi Scaradavou, Ioannis Politikos, Amanda Blouin, Brian C. Shaffer, Juliet N Barker

Blood (2023) 142 (Supplement 1): 3759.

https://doi.org/10.1182/blood-2023-180416

Published: 2023

Journal Articles

High Progression-Free Survival with Low Relapse Rates after Double-Unit Cord Blood Transplantation in Patients with High-Risk AML

Ioannis Politikos, Warren B Fingrut, Samantha Brown, Stephanie Chinapen, Sean Quach, Parastoo B. Dahi, Boglarka Gyurkocza, Ann A. Jakubowski, Esperanza B. Papadopoulos, Doris M. Ponce, Roni Tamari, Miguel-Angel Perales, Andromachi Scaradavou, Juliet N Barker

Blood (2023) 142 (Supplement 1): 2209.

https://doi.org/10.1182/blood-2023-190836

Published: 2023

Journal Articles

TNC/Kg and CD34+/Kg Cell Dose Impact on Patient Engraftment after Allogeneic Transplant with Conventional Bone Marrow; Better Predictability of Graft Content Needed

Eric Davis, Elise Feuer, Candice Rapoport, Stephanie Lobaugh, Sean M. Devlin, Anne Archer, Stephanie Chinapen, Jacob Federman, Amanda Kelly, Elizabeth Klein, Melissa Nhaissi, Deborah Wells, Juliet N Barker, Esperanza B. Papadopoulos, Andromachi Scaradavou, Jaap Jan Boelens, Miguel-Angel Perales, Elena Maryamchik, Roni Tamari

Blood (2023) 142 (Supplement 1): 113.

https://doi.org/10.1182/blood-2023-190940

Published: 2023

Journal Articles

A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract

Blood (2023) 141 (12): 1389–1401.

https://doi.org/10.1182/blood.2021015111

Published: 2023

Includes: Supplemental data

Journal Articles

Tracking Immune Reconstitution in the Bone Marrow Following Allogeneic Hematopoietic Transplantation in Humans Reveals Early Dominance of Innate Lymphoid Populations

Blood (2022) 140 (Supplement 1): 4759–4761.

https://doi.org/10.1182/blood-2022-159303

Published: 2022

Journal Articles

Outcomes and Management of Sars-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and CAR-T Therapy

Maria Stefania Infante, Susan DeWolf, Roni Tamari, Parastoo B. Dahi, Yeon Joo Lee, Ioannis Politikos, Juliet N. Barker, N. Esther Babady, Lakshmi Ramanathan, Susan Seo, Sergio A. Giralt, Mini Kamboj, Miguel-Angel Perales, Gunjan L. Shah

Blood (2022) 140 (Supplement 1): 4792–4794.

https://doi.org/10.1182/blood-2022-166393

Published: 2022

Journal Articles

Analysis of 372 Adult Allograft Recipients Reveals Associations between Non-European Ancestry, Low Socioeconomic Status, and Receipt of HLA-Disparate Grafts

Warren Fingrut, Stephanie Chinapen, Angela Katrichis, Caroline Carino, Eric Davis, Brian C. Shaffer, Christina Cho, Gunjan L. Shah, Juliet N. Barker

Blood (2022) 140 (Supplement 1): 313–314.

https://doi.org/10.1182/blood-2022-168486

Published: 2022

Journal Articles

Prospective Analysis to Determine Barriers to Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed and Relapsed Acute Leukemia

Blood (2022) 140 (Supplement 1): 2137–2139.

https://doi.org/10.1182/blood-2022-157193

Published: 2022

Journal Articles

Racial Disparities in Access to Alternative Donor Allografts Persist in the Era of "Donors for All"

Warren Fingrut, Ioannis Politikos, Eric Davis, Stephanie Chinapen, Kristine Naputo, Christina Cho, Sergio A Giralt, Boglarka Gyurkocza, Ann A Jakubowski, Esperanza B Papadopoulos, Miguel-Angel Perales, Doris M Ponce, Andromachi Scaradavou, Brian C Shaffer, Juliet N Barker

Blood (2021) 138 (Supplement 1): 423.

https://doi.org/10.1182/blood-2021-147329

Published: 2021

Journal Articles

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Jason Dehn, Stephen Spellman, Carolyn K. Hurley, Bronwen E. Shaw, Juliet N. Barker, Linda J. Burns, Dennis L. Confer, Mary Eapen, Marcelo Fernandez-Vina, Robert Hartzman, Martin Maiers, Susana R. Marino, Carlheinz Mueller, Miguel-Angel Perales, Raja Rajalingam, Joseph Pidala

Blood (2019) 134 (12): 924–934.

https://doi.org/10.1182/blood.2019001212

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Patients with Myelodysplastic Syndromes

Bartlomiej Getta, MBBS,, Ashwin Kishtagari, MD, Patrick Hilden, MS, Sean Devlin, PhD, Molly A. Maloy, MS, Patrick K. Gonzales, Brian C. Shaffer, MD, Doris M Ponce, MD, Boglarka Gyurkocza, MD, Juliet N. Barker, MBBS, Esperanza B. Papadopoulos, MD, Hugo Castro-Malaspina, MD, Ann A. Jakubowski, MD PhD, James W. Young, MD, Martin S. Tallman, MD, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Roni Tamari, MD, Virginia M. Klimek, MD

Blood (2016) 128 (22): 3188.

https://doi.org/10.1182/blood.V128.22.3188.3188

Published: 2016

Journal Articles

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Carmen Lau, PharmD, Valkal Bhatt, PharmD, Parastoo B. Dahi, MD, Sean Devlin, PhD, Yeon Yoo, BS, Nelly G. Adel, PharmD, BCOP, BCPS, Chris Mazis, Miguel Perales, MD, Sergio A. Giralt, MD, Guenther Koehne, MD PhD, Doris M Ponce, MD, Genovefa A Papanicolaou, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 2219.

https://doi.org/10.1182/blood.V128.22.2219.2219

Published: 2016

Journal Articles

A Novel Intermediate Intensity Conditioning Regimen Achieves High Rates of Long-Term Outpatient Progression-Free Survival Offsetting the Disadvantage of Early Post-Transplant Complications in Adult Cord Blood (CB) Transplant Recipients

Ioannis Politikos, MD, Sean Devlin, PhD, Yeon Yoo, BS, Christopher Mazis, BS, Molly A. Maloy, MS, Andromachi Scaradavou, MD, Parastoo B. Dahi, MD, Miguel Perales, MD, Sergio Giralt, MD, Doris M Ponce, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 2193.

https://doi.org/10.1182/blood.V128.22.2193.2193

Published: 2016

Journal Articles

Despite Increasing Size of Unrelated Donor (URD) Registries and the Global Cord Blood (CB) Inventory Racial Disparities in Access to URD and CB Grafts Persist: A Prospective 10 Year Analysis of 1,112 Patients

Kirsten Boughan, MD, Parastoo B. Dahi, MD, Sean Devlin, PhD, Courtney Byam, BS, CHTC, Yeon Yoo, BS, Christopher Mazis, BS, Eric Davis, CHTC, Melissa Nhaissi, MPH, Jennifer Paulson, MBS, CHTC, Deborah Wells, MA, CHTC, Candice Cooper, BS, Doris M Ponce, MD, Sergio Giralt, MD, Esperanza B. Papadopoulos, MD, Nancy A. Kernan, MD, Andromachi Scaradavou, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 821.

https://doi.org/10.1182/blood.V128.22.821.821

Published: 2016

Journal Articles

The Disease Risk Index Predicts Outcomes Including Relapse and Survival in CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Christina Cho, MD, Patrick Hilden, MS, Jonathan U. Peled, MD PhD, Scott T. Avecilla, MD PhD, Pere Barba, MD, Juliet N. Barker, MBBS (Hons), Hugo R. Castro-Malaspina, MD, Sergio A. Giralt, MD, Ann A. Jakubowski, MD PhD, Guenther Koehne, MD PhD, Richard C. Meagher, PhD, Molly A. Maloy, MS, Richard J. O'Reilly, MD, Esperanza B. Papadopoulos, MD, Doris M. Ponce, MD, Marcel R. M. van den Brink, MD PhD, James W. Young, MD, Miguel-Angel Perales, MD

Blood (2016) 128 (22): 3498.

https://doi.org/10.1182/blood.V128.22.3498.3498

Published: 2016

Journal Articles

Age-Adjusted Co-Morbidity Score - but Not Revised Disease Risk Index - Is Associated with Progression-Free Survival after Intermediate Intensity Double Unit CBT in Adults with Hematologic Malignancies

Blood (2015) 126 (23): 3231.

https://doi.org/10.1182/blood.V126.23.3231.3231

Published: 2015

NARROW

A Balancing Act: Outcomes of Post-Transplant Cyclophosphamide in Older Patients

Non-White and Hispanic Patients Have Significantly Longer Time from Intent to CAR T Infusion (“Brain-to-Vein” Time) in Multiply Relapsed Diffuse Large B Cell Lymphoma

Optimized Double-Unit Cord Blood Transplantation Mitigates Transplant-Related Mortality Resulting in High Progression-Free Survival in Adults with Hematologic Malignancies

Analysis of 3,843 Unrelated Donors (URD) for 455 Allograft Candidates Reveals Low URD Availability with Marked Racial/ Ethnic Disparities: Major Implications for Transplant Center & Registry Operations

Gender Disparities in Allograft Access Due to HLA-Sensitization in Multiparous Women: Implications for Evaluation of Female Patients for Alternative Donor Transplantation

High Progression-Free Survival with Low Relapse Rates after Double-Unit Cord Blood Transplantation in Patients with High-Risk AML

TNC/Kg and CD34+/Kg Cell Dose Impact on Patient Engraftment after Allogeneic Transplant with Conventional Bone Marrow; Better Predictability of Graft Content Needed

A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract

Tracking Immune Reconstitution in the Bone Marrow Following Allogeneic Hematopoietic Transplantation in Humans Reveals Early Dominance of Innate Lymphoid Populations

Outcomes and Management of Sars-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and CAR-T Therapy

Analysis of 372 Adult Allograft Recipients Reveals Associations between Non-European Ancestry, Low Socioeconomic Status, and Receipt of HLA-Disparate Grafts

Prospective Analysis to Determine Barriers to Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed and Relapsed Acute Leukemia

Racial Disparities in Access to Alternative Donor Allografts Persist in the Era of "Donors for All"

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Patients with Myelodysplastic Syndromes

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

A Novel Intermediate Intensity Conditioning Regimen Achieves High Rates of Long-Term Outpatient Progression-Free Survival Offsetting the Disadvantage of Early Post-Transplant Complications in Adult Cord Blood (CB) Transplant Recipients

Despite Increasing Size of Unrelated Donor (URD) Registries and the Global Cord Blood (CB) Inventory Racial Disparities in Access to URD and CB Grafts Persist: A Prospective 10 Year Analysis of 1,112 Patients

The Disease Risk Index Predicts Outcomes Including Relapse and Survival in CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Age-Adjusted Co-Morbidity Score - but Not Revised Disease Risk Index - Is Associated with Progression-Free Survival after Intermediate Intensity Double Unit CBT in Adults with Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only